Over 600 million people aged 18–65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countries

Read full text
Authors: Andreas Kattem Husøy, Shengyuan Yu, Ruozhuo Liu, Akbar A. Herekar, Bilal Ahmed, Arif D. Herekar, Callixte Kuate Tegueu, Anastase Dzudie Tamdja, Annick Mélanie Magnerou, Najib Kissani, Latifa Adarmouch, Thierry Adoukonou
+29 more Mendinatou Agbétou, Oyéné Kossi, Mehila Zebenigus, Redda Tekle‐Haimanot, Dawit K. Worku, Girish Nagaraja Rao, GirishB Kulkarni, Gopalkrishna Gururaj, Mohammed Al Jumah, Ali M. Al Khathaami, Suliman Kojan, Guiovanna Quispe, Carlos Palomino-Diaz, Youssoufa Maïga, RP Cowan, Mattias Linde, Ajay Risal, Debashish Chowdhury, Krishnan Anand, Ashish Duggal, Otgonbayar Luvsannorov, Dorjkhand Baldorj, Selenge Enkhtuya, Ilya Ayzenberg, Zaza Katsarava, Gretchen Lano Birbeck, Daiva Rastenytė, Lars Jacob Stovner, Timothy J. Steiner
Cited by: 1
References: 46

Abstract

BACKGROUND: Our recent estimate of the global 1-year prevalence of headache among those aged 18-65 years was 65%: considerably higher than previous estimates, but based solely on high-quality epidemiological data derived from a large population-based sample. Here we present complementary estimates of 1-day prevalence. METHODS: We performed a meta-analysis of individual participant data from cross-sectional surveys among population-representative samples (age range 18-65 years) from 15 countries and all world regions. All used the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) questionnaire, including the question "did you have a headache yesterday?", from which 1-day prevalence was determined. An algorithmic process applying modified ICHD criteria yielded separate estimates for migraine, tension-type headache (TTH) and probable medication-overuse headache (pMOH: the association of headache on ≥ 15 days/month and medication overuse). We analysed associations with age, gender and country-income level, and adjusted prevalence estimates for these factors. We calculated predicted 1-day prevalence from 1-year prevalence and reported headache frequency. RESULTS: Among the 38,512 participants, females (53.4%) and participants from low- (17.1%) or lower-middle-income countries (64.6%) were overrepresented, but age distribution fairly matched that of the world. Overall, 13.7% (95% CI: 13.3-14.0) reported headache yesterday, females (17.1% [16.6-17.6]) more than males (9.7% [9.3-10.2]). Migraine was the most common headache type yesterday (6.0% [5.8-6.3]), followed by TTH (4.1% [3.9-4.3]) and pMOH (2.3% [2.2-2.5]). One-day headache prevalence was higher in low/lower-middle-income countries (13.9% [13.6-14.3]) than in high/upper-middle-income countries (12.4% [11.6-13.2]). Predicted 1-day prevalence (10.9% [10.7-11.1]) was considerably lower than observed 1-day prevalence (13.7% [13.3-14.0]), although not among those with pMOH (3.1% [3.0-3.3] versus 2.3% [2.2-2.5]). Adjusted for age, gender and country-income level, global 1-day prevalence estimates were 13.1% (12.8-13.5) for any headache, 5.7% (5.5-5.9) for migraine, 3.9% (3.7-4.1) for TTH and 2.4% (2.3-2.6) for pMOH, with 1.0% undiagnosed. CONCLUSION: Assuming yesterday was no different from any other day, an estimated 13.1% (N = 641,900,000) of the world's population aged 18-65 years will have headache tomorrow; almost half will be migraine. People with migraine or TTH underestimate the frequency of headache episodes. Since headache-attributed burden is usually estimated from recalled frequency over 1-12 months, this also may be underestimated.

Fields of Study & Subjects

Migraine and Headache Studies Musculoskeletal pain and rehabilitation Cardiovascular Health and Risk Factors

Publication details

Journal / source
The Journal of Headache and Pain
Publisher
Springer Science and Business Media LLC
Volume
27
Issue
1
Publication date
25 May 2026
Language
EN